Weissel M, Weber H, Probst P, Höfer R
Acta Med Austriaca. 1984;11(3-4):113-7.
Thyroid function was investigated in 41 patients on chronic treatment with amiodarone. 27% of the patients had elevated total thyroxine levels together with elevated free thyroxine levels. Thyrotropin (TSH) secretion was completely suppressed in 15% of the patients. Elevated free or total thyroxine levels were frequently observed together with normal TSH secretion, although 5 of the 6 patients with suppressed TSH had markedly elevated levels. Triiodothyronine (T3) levels were low normal or below the normal range in all patients but one. This was the only patient who apparently developed amiodarone-induced hyperthyroidism. The clinical symptoms of this patient were equivocal. Thyroid function parameters including T3 levels returned to normal only 3 months after withdrawal of the drug. The patient did not need any thyrostatic treatment. The duration of treatment with amiodarone did not influence thyroid hormone concentrations, although there was an insignificant trend of increasing total thyroxine levels after a year of treatment. There was, moreover, no significant influence of the dose (200-500 mg orally/day) of amiodarone on thyroid hormone levels. Our results show that the usual screening parameters of thyroid function, namely total and free thyroxine serum concentrations, are not reliable in patients on chronic amiodarone treatment. The incidence of amiodarone-induced hypothyroidism was 2.4%. We did not observe an amiodarone-induced hypothyroidism, although there was one patient with increased TSH levels but normal T3 and thyroxine levels.
对41例接受胺碘酮长期治疗的患者进行了甲状腺功能调查。27%的患者总甲状腺素水平升高,同时游离甲状腺素水平也升高。15%的患者促甲状腺激素(TSH)分泌完全受到抑制。尽管6例TSH受抑制的患者中有5例甲状腺素水平明显升高,但游离或总甲状腺素水平升高时TSH分泌通常正常。除1例患者外,所有患者的三碘甲状腺原氨酸(T3)水平均略低于正常范围或在正常范围以下。这是唯一一名明显发生胺碘酮所致甲状腺功能亢进的患者。该患者的临床症状不明确。仅在停药3个月后,包括T3水平在内的甲状腺功能参数才恢复正常。该患者不需要任何抗甲状腺药物治疗。尽管治疗一年后总甲状腺素水平有轻微升高趋势,但胺碘酮的治疗时间并不影响甲状腺激素浓度。此外,胺碘酮剂量(口服200 - 500 mg/天)对甲状腺激素水平也没有显著影响。我们的结果表明,在接受胺碘酮长期治疗的患者中,常用的甲状腺功能筛查参数,即血清总甲状腺素和游离甲状腺素浓度,并不可靠。胺碘酮所致甲状腺功能减退的发生率为2.4%。我们未观察到胺碘酮所致的甲状腺功能减退,尽管有1例患者TSH水平升高,但T3和甲状腺素水平正常。